FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome
暂无分享,去创建一个
A. Hattersley | K. Patel | S. Flanagan | E. De Franco | J. Houghton | R. Bacchetta | S. Olek | Steffi Walter | Matthew B. Johnson | R. Wyatt | Janika J. Schulze | Bjoern Samans
[1] K. Weinberg,et al. Epigenetic and Immunological Indicators of IPEX Disease in subjects with FOXP3 gene mutation. , 2022, The Journal of allergy and clinical immunology.
[2] E. Meffre,et al. Loss of FOXP3 function causes expansion of two pools of autoreactive T cells in patients with IPEX syndrome , 2022, bioRxiv.
[3] S. Ellard,et al. Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of MODY , 2021, Diabetes.
[4] S. Ellard,et al. Rapid genomic testing for critically ill children: time to become standard of care? , 2021, European Journal of Human Genetics.
[5] E. Gambineri,et al. Atypical Presentations of IPEX: Expect the Unexpected , 2021, Frontiers in Pediatrics.
[6] A. McWhinnie,et al. Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR , 2020, PloS one.
[7] M. Rashid,et al. IPEX Syndrome with Normal FOXP3 Protein Expression in Treg Cells in an Infant Presenting with Intractable Diarrhea as a Single Symptom , 2020, Case reports in immunology.
[8] S. Ellard,et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020 , 2020 .
[9] H. Kanegane,et al. Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome , 2019, Pediatric diabetes.
[10] D. Lazarević,et al. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies , 2019, Front. Immunol..
[11] H. Ochs,et al. Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome , 2018, Front. Immunol..
[12] U. Sack,et al. Epigenetic immune cell counting in human blood samples for immunodiagnostics , 2018, Science Translational Medicine.
[13] F. Rieux-Laucat,et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study , 2017, The Journal of allergy and clinical immunology.
[14] B. Christensen,et al. Cell-type deconvolution from DNA methylation: a review of recent applications , 2017, Human molecular genetics.
[15] A. Hattersley,et al. Monogenic autoimmune diseases of the endocrine system. , 2016, The lancet. Diabetes & endocrinology.
[16] A. Hattersley,et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study , 2015, The Lancet.
[17] R. Bacchetta,et al. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..
[18] C. Cancrini,et al. Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome , 2012, Journal of autoimmunity.
[19] Thorsten Dickhaus,et al. Epigenetic quantification of tumor-infiltrating T-lymphocytes , 2011, Epigenetics.
[20] Alf Hamann,et al. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? , 2009, Nature Reviews Immunology.
[21] A. Hattersley,et al. Clinical Heterogeneity in Patients With FOXP3 Mutations Presenting With Permanent Neonatal Diabetes , 2009, Diabetes Care.
[22] W. Friedrich,et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. , 2008, The Journal of allergy and clinical immunology.
[23] I. Türbachova,et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells , 2007, European journal of immunology.
[24] S. Ziegler,et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. , 2006, The Journal of clinical investigation.
[25] A. Ugazio,et al. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.